Insiders · Profile

Baumann Oliver Rolf

Director at Veraxa Biotech AG - Post de-SPAC. Filing since 27 Aug 2026. CIK 0002129436

Company

Date

Role

Action

Shares

Amount

Of holding

VRXA Veraxa Biotech AG - Post de-SPAC

27 Aug 2026

Director

Bought

50,000

$75.00K

0.9%

1 decision on file.